All News #Library
Rare Diseases
Innate Pharma Announces FDA Clearance to Proceed With TELLOMAK 3
10 Nov 2025 //
BUSINESS WIRE
Innate Pharma Reports Durable Lacutamab Results
23 May 2025 //
BUSINESSWIRE

Market Place
Sourcing Support